BofA analyst Michael Ryskin lowered the firm’s price target on 10x Genomics (TXG) to $12 from $16 and keeps a Neutral rating on the shares.

10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell ...

PLEASANTON, Calif., April 14, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced it will report financial results for the first quarter ...

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the Americas, Europe, the Middle East ...

A study by scientists at the Herbert Irving Comprehensive Cancer Center (HICCC) introduces a more cost-effective, scalable ...

An accidental discovery sparks a new technique DEFND-seq leverages an existing commercial droplet microfluidics system from 10x Genomics, a platform that is widely and routinely used in single ...

The 10X rule is about looking at what you want in life and then thinking 10 times more scale. The hope is that you will find a greater sense of purpose and wealth by going from average to ...

GAITHERSBURG, Md. & OAKLAND, Calif. – GeneDx, a genomic insights company, announced its intent to acquire Fabric Genomics, a company specializing in AI-powered genomic interpretation.

Ethereum exchange platforms currently hold 10.2 million ETH in reserves which represents the lowest amount seen since mid-2024 despite a 63% decrease from November 2025. Analysts maintain an ...